Kala Bio KALA
NASDAQ KALA
$0.82 -0.02 (-2.39%)
As of: Aug 21, 2026 · 3:58 PM EDT

Kala Bio (KALA) Property, Plant & Equipment (Net) (2016 - 2025)

Kala Bio (KALA) Property, Plant & Equipment (Net) (2016 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 1.67 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 5.46 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 1.96 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 2.06 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 1.64 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 554.14 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 6.80 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 107.22 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Kala Bio 9.89 Mn 9.89 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2025 603,000.00
Sep 30, 2025 603,000.00
Jun 30, 2025 657,000.00
Jun 30, 2025 657,000.00
Mar 31, 2025 695,000.00
Mar 31, 2025 695,000.00
Dec 31, 2024 749,000.00
Dec 31, 2024 749,000.00
Sep 30, 2024 762,000.00
Sep 30, 2024 762,000.00
Jun 30, 2024 617,000.00
Jun 30, 2024 617,000.00
Mar 31, 2024 714,000.00
Mar 31, 2024 714,000.00
Dec 31, 2023 753,000.00
Dec 31, 2023 753,000.00
Sep 30, 2023 802,000.00
Sep 30, 2023 802,000.00
Jun 30, 2023 637,000.00
Jun 30, 2023 637,000.00